Ausgabe 1/2016
Inhalt (10 Artikel)
Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis
N. Nakayama, K. Yamashita, T. Tanaka, H. Kawamata, A. Ooki, T. Sato, T. Nakamura, M. Watanabe
Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo
Justyna Mikuła-Pietrasik, Patrycja Sosińska, Eryk Naumowicz, Konstantin Maksin, Hanna Piotrowska, Aldona Woźniak, Dariusz Szpurek, Krzysztof Książek
Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer
Shanna A. Arnold, Holli A. Loomans, Tatiana Ketova, Claudia D. Andl, Peter E. Clark, Andries Zijlstra
Tip60 regulates MT1-MMP transcription and invasion of glioblastoma cells through NF-κB pathway
Takahisa Takino, Mitsutoshi Nakada, Zichen Li, Taisuke Yoshimoto, Takahiro Domoto, Hiroshi Sato
Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease
Evan L. Busch, Temitope O. Keku, David B. Richardson, Stephanie M. Cohen, David A. Eberhard, Christy L. Avery, Robert S. Sandler
S100A11 is a potential prognostic marker for clear cell renal cell carcinoma
Manal Gabril, Hala Girgis, Andreas Scorilas, Fabio Rotondo, Samantha Wala, Georg A. Bjarnason, Qiang Ding, Andrew Evans, Eriny Tawedrous, Maria Pasic, Antonio Finelli, Sahar Al-Haddad, George M. Yousef
Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma
Wei Guo, Zhiming Dong, Jianli Cui, Yanli Guo, Supeng Shen, Xin Guo, Gang Kuang
Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases
Arong Gaowa, Tomohisa Horibe, Masayuki Kohno, Hiroshi Harada, Masahiro Hiraoka, Koji Kawakami
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
Mauricio Rodriguez-Torres, Alison L. Allan